Ophthalmology conditions Flashcards
AMD
Progressive disease affecting the macula classified by a number of physical characteristics, in particular the number and consistency of drusen
Most common cause of blindness in the UK
AMD risk factors
Age - AMD increases with age
Smoking
Caucasian
Concomitant diseases - CVD, HTN
Ocular characteristics - light iris, hyperopia
Genetics - complement factor H, gene variant Y402H
Dry AMD
Less aggressive form, accounts for between 80-90% of all AMD
Initially no apparent symptoms but drusen present
Visual loss caused by atrophy or conversion to wet AMD
Wet AMD
New vessels develop from the choroid layer and grow into the retina (neovascularisation)
Vessels can leak fluid or blood, causing oedema and faster vision loss
VEGF stimulates the development of new vessels
AMD vs glaucoma
Glaucoma - associated with peripheral vision loss and halos around lights
AMD - associated with central vision loss and a wavy appearance to straight lines
AMD presentation
Unilateral
Gradual loss of central vision
Reduced visual acuity
Crooked or wavy appearance to straight lines (metamorphopsia)
Gradually worsening ability to read small text
Wet AMD presents more acutely than dry AMD → can progress to complete vision loss within 2-3 years & bilateral disease
AMD examination
Reduced visual acuity using a Snellen chart
Scotoma (enlarged central area of vision loss)
Amsler grid test - used to assess for the distortion of straight lines seen in AMD
Drusen may be seen in fundoscopy
AMD Ix
Slit lamp examination - detailed view of the retina and macula
Optical CT - used to diagnose and monitor AMD
Fluorescein angiography - assess retina blood supply → shows oedema & neovascularisation in wet AMD
AMD management
Require specialist ophthalmology assessment and management
No specific treatment for dry AMD, reducing risk of progression:
- avoiding smoking
- controlling BP
- vitamin supplementation has some evidence in slowing progression
Wet AMD - anti-VEGF medications (eg. ranibizumab) block VEGF & slow the development of new vessels
- injected directly into the vitreous chamber of the eye, usually about once a month
Charles Bonnet syndrome
Causes a person whose vision has started to deteriorate to see things that aren’t real
Brain doesn’t receive as much information as it used to and responds by filling in the gaps with fantasy patterns or images that it’s stored
Reassuring patients is essential to help them cope with hallucinations
Uveitis classification
Anatomical location - anterior (iris), intermediate (ciliary body), posterior (choroid)
Granulomatous vs non-granulomatous
Acute, recurrent or chronic
- recurrent - more than 3 months
- chronic - less than 3 months
Uveitis aetiology
Autoimmune - sarcoid, SLE, MS, Behcets, seronegative spondyloarthropathies, IBD
Infectious - CMV, HSV, HZV, candida, toxoplasma
Drug induced - bisphosphonates
Traumatic
Anterior uveitis clinical features
Symptoms - blurring of vision, pain, photophobia, redness of eye, floaters
Signs - keratic precipitates, cells in anterior chamber, fibrin in anterior chamber, flare in anterior chamber, posterior synechae (posterior part of the iris can get stuck to the lens during inflammation), cells in vitreous, choroiditis lesions, macular oedema
Uveitis investigations
Infectious vs non infectious
FBC, U&Es, LFT, Q Gold (TB), treponemal antibody (syphilis)
Other investigations dependent on suspected cause
Uveitis management
Anterior uveitis - topical steroids/subconjunctival steroids, cycloplegics
- cycloplegics - dilate the pupil & reduce pain associated with ciliary spasm
- topical steroids SE: ocular hypertension → glaucoma, posterior subcapsular cataract
Intermediate and posterior uveitis
- local treatment: periocular steroids, intravitreal steroid implants
- systemic treatment: pulse therapy, oral steroids, immunosuppression, aetiology specific antibiotic/antifungal/antiviral
- SE of steroids: insomnia, weight gain, osteoporosis, hyperglycaemia, immunosuppression, hypertension
Anterior uveitis complications
Posterior synechiae
Pupillary membrane
Ocular hypertension/glaucoma
Hypotony → no treatment so will lead to blindness
Cataract
Cystoid macular oedema
Glaucoma
Glaucoma - refers to optic nerve damage (characteristic optic head changes), associated with corresponding visual field defects, with or without raised intraocular pressure
Raised pressure caused by a blockage in aqueous humour trying to escape the eye
Main cause of irreversible blindness in the world
Two types: open-angle glaucoma, acute angle-closure glaucoma
Open-angle glaucoma pathophysiology
Gradual increase in resistance to flow through the trabecular meshwork
Pressure slowly builds within the eye
Raised intraocular pressure causes cupping of the optic disc → cup-disk ratio > 0.5 is abnormal
Open-angle glaucoma risk factors
Increasing age
Family history
Black ethnic origin
Myopia (nearsightedness)
Eye injuries/eye operations
Ocular hypertension
Open-angle glaucoma presentation
Rise in intraocular pressure may be asymptomatic for a long time & diagnosed by routine eye testing
Glaucoma affects the peripheral vision first → gradual onset of peripheral vision loss (tunnel vision)
Fluctuating pain
Headaches
Blurred vision
Halos around lights, particularly at night
Measuring intraocular pressure
Non-contact tonometry: estimates intraocular pressure by opticians; involves shooting a ‘puff of air’ at the cornea
Goldmann applanation tonometry - gold-standard to measure intraocular pressure → involves a device mounted on a slip lamp that makes contact with the cornea & applies various pressures
Open-angle glaucoma diagnosis
Goldmann applanation tonometry
Slit lamp
Visual field assessment
Gonioscopy
Central corneal thickness
Open-angle glaucoma management
360 degrees selective laser trabeculoplasty → laser directed at the trabecular meshwork, improving drainage
- may delay/prevent the need for eye drops
Next line: prostaglandin analogue eye drops (latanoprost) - increase uveoscleral outflow
- SE: eyelash growth, eyelid pigmentation, iris pigmentation
Other eye drop options: beta-blockers, carbonic anhydrase inhibitors, sympathomimetics
Open-angle glaucoma surgery
360 degree selective laser trabeculoplasty (SLT) first line to people with an IOP > 24mmHg
Trabeculectomy may be considered in refractory cases
Acute angle closure glaucoma
Iris bulges forward and seals off the trabecular meshwork from the anterior chamber → prevents aqueous humour from draining & leads to continual increase in intraocular pressure
The pressure builds in the posterior chamber, pushing the iris forward & exacerbating angle closure
Ophthalmological emergency
Acute angle closure glaucoma risk factors
Long-sightedness
Increasing age
Family history
Female
Chinese and east asian ethnic origin
Shallow anterior chamber
Certain medications - adrenergic medication, anticholinergic medications, tricyclic antidepressants
Acute angle-closure glaucoma presentation
Appears generally unwell
Severely painful red eye
Blurred vision
Halos around lights
Associated headache, nausea & vomiting
Signs: red eye, hazy cornea, decreased visual acuity, mid-dilated pupil, fixed size pupil, hard eyeball on gentle palpation
Acute-angle closure glaucoma initial management
Immediate admission
Lie patient flat without a pillow
Pilocarpine eye drops
Acetazolamide 500mg orally
Analgesia & anti-emetic
Acute-angle closure secondary care management
Specialist medical options - pilocarpine eye drops, acetazolamide IV, timolol, brimonidine
Laser iridotomy = definitive treatment
- relieves pressure pushing iris forward against the cornea & opens the pathway for the aqueous humour to drain
Central retinal artery occlusion
Sudden, painless loss of vision caused by occlusion of the central retinal artery
Less common than retinal vein occlusion
More proximal an occlusion is, the worse effect on vision
CRAO aetiology
Atherosclerosis
Embolism
Inflammatory
Thrombophilia
CRAO clinical features
Sudden-onset painless loss of vision typically occurring over seconds
History of amaurosis fugax (transient loss of vision)
O/E - pale retina with a ‘cherry red spot’ at the macula, may also have a RAPD
CRAO investigations
Fundoscopy & thorough H&E
Imaging - OCT & fluorescein angiography may also be utilised
CRAO management
Vision unlikely to improve with treatment beyond 90-100 minutes - only 30% of patients will have any improvement in vision after presentation
Aim is to reperfuse the ischaemic retina as quickly as possible:
- ocular massage - aiming to dislodge the embolus
- vasodilation with isosorbide dinitrate
- anterior chamber paracentesis - reduce IOP to help dislodge the embolus
CRVO
Central retinal vein (or one of its branches) is occluded by a thrombus
More common than central retinal artery occlusion
CRVO risk factors
Atherosclerotic - age, smoking, obesity, hypertension, diabetes
Haematological - protein S, protein C or antithrombin deficiency, factor V Leiden, multiple myeloma, glaucoma, antiphospholipid syndrome
CRVO clinical features
Sudden, painless loss of vision/visual field defects
Ischaemic CRVO → must worse reduced visual acuity (6/60 or worse)
O/E - classic fundoscopy description is ‘stormy sunset’ with findings that include:
- numerous flame haemorrhages
- dot & blot haemorrhages
- cotton wool spots
- retinal oedema
- dilated/tortuous retinal veins
- visual field defects
CRVO investigations
Bloods - FBC, ESR, CRP, U&Es, LFTs, lipid profile, clotting screen
Further screening for thrombophilia if pt has a family history of clotting disorders
CRVO management
Immediate referral to ophthalmology
Conservative management
Retinal neovascularisation - laser photocoagulation
Macular oedema - intravitreal anti-VEGF injections
CRVO complications
Neovascularisation
Vitreous haemorrhage - new vessels are fragile and can bleed
Hyphaema - neovascularisation in the iris can lead to bleeding in the anterior chamber
Episcleritis
Benign and self-limiting inflammation of the episclera, the outermost layer of the sclera
Relatively common in young & middle-aged adults, often associated with inflammatory disorders
Episcleritis clinical features
Localised/diffuse redness (often a patch of redness in the lateral sclera
No pain
Dilated episcleral vessels
No photophobia/discharge
Normal visual acuity
Applying phenylephrine eye drops → causes blanching episcleral vessels → causes redness to disappear
Episcleritis management
Self-limiting & will resolve in 1-2 weeks
Symptoms may be relieved with analgesia & lubricating eye drops
More severe cases → steroid eye drops
Scleritis
Inflammation of the sclera
Most severe type = necrotising scleritis → lead to perforation of the sclera
Scleritis aetiology
Idiopathic
Underlying systemic inflammatory condition - RA, vasculitis
Infection - pseudomonas or staph aureus
Scleritis clinical features
Gradual onset, can be unilateral or bilateral
Red, inflamed sclera
Congested vessels
Severe pain
Pain with eye movement
Photophobia
Epiphora (excessive tear production)
Reduced visual acuity
Tenderness to palpation of the eye
Scleritis management
Urgent assessment and management by an ophthalmologist
Oral NSAIDs
Steroids - topical or systemic
Immunosuppression appropriate to underlying systemic condition
Antimicrobials for infectious scleritis
Diabetic retinopathy
Involves damage to the retinal blood vessels due to prolonged high blood sugar levels